clofibric acid has been researched along with Acute Coronary Syndrome in 2 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Acute Coronary Syndrome: An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Betaine is an osmolyte, supplies methyl groups, and controls plasma homocysteine." | 2.74 | Fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine. ( Chambers, ST; Elmslie, JL; Fink, JN; George, PM; Lever, M; Richards, AM; Scott, RS; Slow, S, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosenson, RS | 1 |
| Pitt, B | 1 |
| Lever, M | 1 |
| George, PM | 1 |
| Slow, S | 1 |
| Elmslie, JL | 1 |
| Scott, RS | 1 |
| Richards, AM | 1 |
| Fink, JN | 1 |
| Chambers, ST | 1 |
1 trial available for clofibric acid and Acute Coronary Syndrome
| Article | Year |
|---|---|
Fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine.
Topics: Acute Coronary Syndrome; Aged; Betaine; Clofibric Acid; Cohort Studies; Diabetes Complications; Fema | 2009 |
1 other study available for clofibric acid and Acute Coronary Syndrome
| Article | Year |
|---|---|
Triglycerides and cardiovascular events in ACS: the need for combined lipid-altering therapies.
Topics: Acute Coronary Syndrome; Cardiovascular Diseases; Clofibric Acid; Drug Therapy, Combination; Humans; | 2009 |